Implementation of Pharmacogenomic Clinical Decision Support for Health Systems: A Cost-Utility Analysis

We constructed a cost-effectiveness model to assess the clinical and economic value of a CDS alert program that provides pharmacogenomic (PGx) testing results, compared to no alert program in acute coronary syndrome (ACS) and atrial fibrillation (AF), from a health system perspective. We defaulted t...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shangqing, Mathias, Patrick C., Hendrix, Nathaniel, Shirts, Brian H., Tarczy-Hornoch, Peter, Veenstra, David, Malone, Daniel, Devine, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156556/
https://www.ncbi.nlm.nih.gov/pubmed/35365779
http://dx.doi.org/10.1038/s41397-022-00275-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156556/
https://www.ncbi.nlm.nih.gov/pubmed/35365779
http://dx.doi.org/10.1038/s41397-022-00275-7

Ejemplares similares